[A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
Depierre
A
A
Chastang
C
C
Lebeau
B
B
Clavier
J
J
Milleron
B
B
Brambilla
C
C
Quoix
E
E
Lemarié
E
E
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
D000970:Antineoplastic Agents
Une nécessité: évaluer la chimiothérapie néoadjuvante des cancers bronchiques par un essai randomisé.